0001022079-16-000293.txt : 20160601 0001022079-16-000293.hdr.sgml : 20160601 20160601163908 ACCESSION NUMBER: 0001022079-16-000293 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160527 FILED AS OF DATE: 20160601 DATE AS OF CHANGE: 20160601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doherty Catherine T. CENTRAL INDEX KEY: 0001520897 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 161689705 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS INCORPORATED STREET 2: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 wf-form4_146481353517905.xml FORM 4 X0306 4 2016-05-27 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001520897 Doherty Catherine T. C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 0 1 0 0 SVP, Clin. Franchise Solutions Common Stock 2016-05-27 4 M 0 23667 55.65 A 100402 D Common Stock 2016-05-27 4 M 0 23667 56.82 A 124069 D Common Stock 2016-05-27 4 S 0 23667 77.268 D 100402 D Common Stock 2016-05-27 4 S 0 23667 77.264 D 76735 D Common Stock 3714 I 401(k)/SDCP Stock Options (Right to Buy) 55.65 2016-05-27 4 M 0 23667 55.65 D 2020-02-10 Common Stock 23667.0 0 D Stock Options (Right to Buy) 56.82 2016-05-27 4 M 0 23667 56.82 D 2021-02-15 Common Stock 23667.0 0 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 25, 2016. This transaction was executed in multiple trades at prices ranging from $77.10 to $77.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $77.10 to $77.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vested in three annual installments beginning with the first on February 10, 2011, the second on February 10, 2012 and the final on February 10, 2013. The options vested in three annual installments beginning with the first on February 15, 2012, the second on February 15, 2013 and the final on February 15, 2014. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Catherine T. Doherty 2016-06-01